Select Your Region
Global
Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the trial you look for.
Refine your search
Search
Relapsed or Refractory Follicular Lymphoma
Location
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
We found 2 results for 'RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA'Use the filters to narrow down your search.
1 
Study StatusActive, not recruiting1 A study to evaluate efficacy and safety of mosunetuzumab in combination with lenalidomide in comparison to rituximab in combination with lenalidomide in patients with follicular lymphoma
A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma
- Cancer,
- Non Hodgkin Lymphoma (NHL),
- Relapsed or Refractory Follicular Lymphoma
- NCT04712097, GO42909, 2023-505807-21-00
2 
Study StatusCompleted2 A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Cancer,
- Non Hodgkin Lymphoma (NHL),
- Follicular Lymphoma,
- Relapsed or Refractory Follicular Lymphoma,
- Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT02600897, GO29834, 2015-001999-22